Chiome Bioscience Overview
- Year Founded
-
2005
- Status
-
Public
- Employees
-
65
- Stock Symbol
-
4583
- Investments
-
6
- Share Price
-
$0.48
- (As of Friday Closing)
Chiome Bioscience General Information
Description
Chiome Bioscience Inc is engaged in the discovery and development of antibody drugs, focusing on early-stage research and initial clinical trials. The company operates through two reportable segments: the Drug Discovery segment and the Drug Discovery Support segment. The Drug Discovery segment conducts research on antibody creation for diseases with high unmet medical needs and aims to generate revenue through licensing agreements, upfront payments, milestone payments, and royalties. The Drug Discovery Support segment provides services such as antibody production and related support using proprietary antibody technologies, catering to pharmaceutical and diagnostic companies as well as academic institutions.
Contact Information
Website
www.chiome.co.jpCorporate Office
- Sumitomo Fudosan Nishi-Shinjuku Building 6
- 3-12-1 Honmachi, Shibuya-ku
- Tokyo, 151-0071
- Japan
Corporate Office
- Sumitomo Fudosan Nishi-Shinjuku Building 6
- 3-12-1 Honmachi, Shibuya-ku
- Tokyo, 151-0071
- Japan
Chiome Bioscience Stock Performance
As of 13-Nov-2026, Chiome Bioscience’s stock price is $0.48. Its current market cap is $39.1M with 81.1M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.48 | $0.48 | $0.40 - $0.81 | $39.1M | 81.1M | 1.61M | -$0.08 |
Chiome Bioscience Financials Summary
As of 30-Jun-2026, Chiome Bioscience has a trailing 12-month revenue of $3.98M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 28,919 | 40,721 | 99,190 | 41,838 |
| Revenue | 3,984 | 3,964 | 5,156 | 4,857 |
| EBITDA | (6,515) | (6,694) | (8,624) | |
| Net Income | (5,995) | (6,566) | (6,740) | (8,683) |
| Total Assets | 11,777 | 11,044 | 15,722 | 12,419 |
| Total Debt | 417 | 1,673 | 1,793 | 2,063 |
Chiome Bioscience Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Chiome Bioscience Patents
Chiome Bioscience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025248815-A1 | Antibody or fragment thereof, and anti-influenza vaccine | Pending | 27-May-2024 | ||
| AU-2023410319-A1 | Anti-human cx3cr1 antibody | Pending | 22-Dec-2022 | ||
| EP-4640709-A1 | Anti-human cx3cr1 antibody | Pending | 22-Dec-2022 | ||
| WO-2024135794-A1 | Anti-human cx3cr1 antibody | Inactive | 22-Dec-2022 | ||
| AU-2023300945-A1 | Fusion protein | Pending | 30-Jun-2022 | C07K16/2809 |
Chiome Bioscience Signals
Chiome Bioscience Investments & Acquisitions (6)
Chiome Bioscience’s most recent deal was a Joint Venture with Alfenax Biologics. The deal was made on 01-Dec-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Alfenax Biologics | 01-Dec-2025 | Joint Venture | Drug Discovery | ||
| Biotechnol | 01-Dec-2018 | Merger/Acquisition | Biotechnology | ||
| Trans Chromosomics | 10-Feb-2017 | Corporate | Discovery Tools (Healthcare) | ||
| EVEC | 30-Mar-2016 | Later Stage VC | Biotechnology | ||
| LivTech | 13-Mar-2015 | Secondary Transaction - Private | Drug Discovery |
Chiome Bioscience ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Laboratory Equipment and Services
Subindustry
Rank
Percentile
Chiome Bioscience FAQs
-
When was Chiome Bioscience founded?
Chiome Bioscience was founded in 2005.
-
Where is Chiome Bioscience headquartered?
Chiome Bioscience is headquartered in Tokyo, Japan.
-
What is the size of Chiome Bioscience?
Chiome Bioscience has 65 total employees.
-
What industry is Chiome Bioscience in?
Chiome Bioscience’s primary industry is Drug Discovery.
-
Is Chiome Bioscience a private or public company?
Chiome Bioscience is a Public company.
-
What is Chiome Bioscience’s stock symbol?
The ticker symbol for Chiome Bioscience is 4583.
-
What is the current stock price of Chiome Bioscience?
As of 13-Nov-2026 the stock price of Chiome Bioscience is $0.48.
-
What is the current market cap of Chiome Bioscience?
The current market capitalization of Chiome Bioscience is $39.1M.
-
What is Chiome Bioscience’s current revenue?
The trailing twelve month revenue for Chiome Bioscience is $3.98M.
-
What is Chiome Bioscience’s annual earnings per share (EPS)?
Chiome Bioscience’s EPS for 12 months was -$0.08.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process